Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A therapy for suppressing canonical and noncanonical SARS-CoV-2 viral entry and an intrinsic intrapulmonary inflammatory response.
Leibel SL, McVicar RN, Murad R, Kwong EM, Clark AE, Alvarado A, Grimmig BA, Nuryyev R, Young RE, Lee JC, Peng W, Zhu YP, Griffis E, Nowell CJ, James B, Alarcon S, Malhotra A, Gearing LJ, Hertzog PJ, Galapate CM, Galenkamp KMO, Commisso C, Smith DM, Sun X, Carlin AF, Sidman RL, Croker BA, Snyder EY. Leibel SL, et al. Among authors: alarcon s. Proc Natl Acad Sci U S A. 2024 Jul 23;121(30):e2408109121. doi: 10.1073/pnas.2408109121. Epub 2024 Jul 19. Proc Natl Acad Sci U S A. 2024. PMID: 39028694 Free PMC article.
SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model.
Alves RPDS, Wang YT, Mikulski Z, McArdle S, Shafee N, Valentine KM, Miller R, Verma SK, Batiz FAS, Maule E, Nguyen MN, Timis J, Mann C, Zandonatti M, Alarcon S, Rowe J, Kronenberg M, Weiskopf D, Sette A, Hastie K, Saphire EO, Festin S, Kim K, Shresta S. Alves RPDS, et al. Among authors: alarcon s. Antiviral Res. 2023 Apr;212:105580. doi: 10.1016/j.antiviral.2023.105580. Epub 2023 Mar 20. Antiviral Res. 2023. PMID: 36940916 Free PMC article.
Tissue-resident memory CD8 T cell diversity is spatiotemporally imprinted.
Reina-Campos M, Monell A, Ferry A, Luna V, Cheung KP, Galletti G, Scharping NE, Takehara KK, Quon S, Challita PP, Boland B, Lin YH, Wong WH, Indralingam CS, Neadeau H, Alarcón S, Yeo GW, Chang JT, Heeg M, Goldrath AW. Reina-Campos M, et al. Among authors: alarcon s. Nature. 2025 Mar;639(8054):483-492. doi: 10.1038/s41586-024-08466-x. Epub 2025 Jan 22. Nature. 2025. PMID: 39843748 Free PMC article.
The spontaneous neoantigen-specific CD4+ T-cell response to a growing tumor is functionally and phenotypically diverse.
Griswold RQ, Brightman SE, Soria Zavala K, Ordaz-Arias MA, Djassemi N, Thota RR, Naradikian MS, Dose H, Alarcon S, Vijayanand P, Peters B, Miller AM, Cohen EEW, Schoenberger SP. Griswold RQ, et al. Among authors: alarcon s. J Immunother Cancer. 2025 Sep 4;13(9):e012209. doi: 10.1136/jitc-2025-012209. J Immunother Cancer. 2025. PMID: 40907998 Free PMC article.
Post-translational modification-centric base editor screens to assess phosphorylation site functionality in high throughput.
Kennedy PH, Alborzian Deh Sheikh A, Balakar M, Jones AC, Olive ME, Hegde M, Matias MI, Pirete N, Burt R, Levy J, Little T, Hogan PG, Liu DR, Doench JG, Newton AC, Gottschalk RA, de Boer CG, Alarcón S, Newby GA, Myers SA. Kennedy PH, et al. Among authors: alarcon s. Nat Methods. 2024 Jun;21(6):1033-1043. doi: 10.1038/s41592-024-02256-z. Epub 2024 Apr 29. Nat Methods. 2024. PMID: 38684783 Free PMC article.
Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk Neuroblastoma.
Villanueva GI, Alarcón S, Bonilla D, Casanovas A, Chaparro M, Coirini MD, Felizzia G, Figueredo D, Fuentes-Alabi S, Ferman S, Franco S, Garcia Lombardi M, Gaytan Morales F, Gregianin LJ, González Ramella Ó, Halley N, Hashimoto C, Ikeda A, Howard S, Juárez Villegas LE, Morosini F, Olaya Vargas A, Odone-Filho V, Pereira de Carvalho Filho N, Peters C, Pérez V, Pérez García M, Pollono A, Rosado R, Romero L, Salazar Rosales HDP, Silva B, Sobrero V, Streitenberger DP, Valencia D, Varela M, Villarroel M. Villanueva GI, et al. Among authors: alarcon s. JCO Glob Oncol. 2025 Dec;11:e2500201. doi: 10.1200/GO-25-00201. Epub 2025 Dec 23. JCO Glob Oncol. 2025. PMID: 41435217
Efficacy and Safety of Risankizumab in Psoriatic Patients With a History of Malignancy: Real-World Evidence From a Multicentre Spanish Study.
Díaz JM, Alarcón SS, Romero IB, Apetrei LS, Fernández LG, Ramos FJM, Alberola FT, Martínez MAB, Ruiz AB, Rodríguez OB, Ruiz-Villaverde R, González MC, Farrés MF, Puchades AM, Tapial JM, Rull EV, Montalvo SM. Díaz JM, et al. Among authors: alarcon ss. Australas J Dermatol. 2025 Dec 5. doi: 10.1111/ajd.70012. Online ahead of print. Australas J Dermatol. 2025. PMID: 41347368
Reducing the Diagnostic Time for Childhood Cancer in Peru: A Hospital-Based Registry Analysis Four Years After Implementation of the Global Initiative for Childhood Cancer.
Pascual C, Vasquez L, Maradiegue E, Palacios V, Montoya J, Maza I, Alarcon S, Rojas N, Godoy V, García H, Chavez S, Ugaz C, Mafaldo A, Leon E, Guzman E, Riojas MC, Garcia E, Atausinchi W, Atanacio J, Aguilar S, Diaz R, Rios N, Tarrillo F, Carpio Z, Huilcanahui M, Moore C, Garcia P, Morales R, Machado C, Paredes R, Rios L, Tello M, Alvarez C, Grados I, Cassana G, Reyes O, Jimenez P, Vargas P, Valdiviezo C, Talavera I, Maza M, Bhakta N, Friedrich P, Lam C, Rodriguez-Galindo C, Birmingham M. Pascual C, et al. Among authors: alarcon s. Pediatr Blood Cancer. 2025 Nov 20:e32158. doi: 10.1002/pbc.32158. Online ahead of print. Pediatr Blood Cancer. 2025. PMID: 41267555
Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial.
ANDROMEDA-SHOCK-2 Investigators for the ANDROMEDA Research Network, Spanish Society of Anesthesiology, Reanimation and Pain Therapy (SEDAR), and Latin American Intensive Care Network (LIVEN); Hernandez G, Ospina-Tascón GA, Kattan E, Ibarra-Estrada M, Ramasco F, Orozco N, Ramos K, Aldana JL, Ferri G, Hamzaoui O, De Backer D, Teboul JL, Vieillard-Baron A, Petri Damiani L, García-Gallardo GA, Morales S, Carmona Garcia P, Mendez R, Hernandez-Gilsoul T, Pérez-Nieto OR, Olea Vielba C, Ramos S, Dominguez D, Bruna M, David S, Wendel-Garcia PD, Galiana-Ivars M, Myatra SN, Messina A, Cecconi M, Pozo M, Amthauer M, Higuera E, Al Duhalib Z, Rico-Feijoo J, Ferrer-Gómez C, Pérez-Carbonell A, Martinez-Castro S, Redondo Calvo FJ, Vives M, Sanchez HF, Bilbao I, Fernandez P, Al-Fares A, Benitez-Cano A, Gonzalez C, Reyes LF, Rodriguez-Guillen JH, Cristino AV, Pendino JC, Ortiz G, Alonso-Gonzalez MC, Murias G, Aguirre-Ávalos G, Hernández L, Calderón Barajas ZA, Zarragoikoetxea I, Monnet X, Goury A, Mendonça Dos Santos T, Vallecilla L, Martins de Lima L, Sady E, Alegria L, Ostermann M, Bakker J, Biasi Cavalcanti A. ANDROMEDA-SHOCK-2 Investigators for the ANDROMEDA Research Network, Spanish Society of Anesthesiology, Reanimation and Pain Therapy (SEDAR), and Latin American Intensive Care Network (LIVEN), et al. JAMA. 2025 Dec 9;334(22):1988-1999. doi: 10.1001/jama.2025.20402. JAMA. 2025. PMID: 41159835 Clinical Trial.
Polyethylene Microplastics and Human Cells: A Critical Review.
Valdivia S, Riquelme C, Carrasco MC, Weisser P, Añazco C, Alarcón A, Alarcón S. Valdivia S, et al. Among authors: alarcon s. Toxics. 2025 Sep 5;13(9):756. doi: 10.3390/toxics13090756. Toxics. 2025. PMID: 41012376 Free PMC article. Review.
114 results